CYP2C19 genotype determines enzyme activity and inducibility of S-mephenytoin hydroxylase

Clinica Chimica Acta

Volumn 313, Issue 1-2, 2001, Pages 203-208

  Zhou, Hong Hao ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

CYP2C19; Diazepam; Ethnic differences; Genetic polymorphism; Omeprazole

Indexed keywords

4' HYDROXYMEPHENYTOIN; CYTOCHROME P450 2C19; DIAZEPAM; DRUG METABOLITE; MEPHENYTOIN; NORDAZEPAM; OMEPRAZOLE; OXYGENASE;

ALLELE; CONFERENCE PAPER; DRUG METABOLISM; ENZYME ACTIVITY; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; PHENOTYPE; PRIORITY JOURNAL;

ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; GENOTYPE; HUMANS; HYDROXYLATION; METHYLATION; MIXED FUNCTION OXYGENASES; POLYMORPHISM, GENETIC;

EID: 0034752109     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(01)00696-9     Document Type: Conference Paper

References (24)

1. Genetic polymorphism of S-mephenytoin hydroxylation
2. Pharmacogenetics of mephenytoin: A new drug hydroxylation polymorphism in man
3. Isolation and characterization of human liver cytochrome P4502C19 correlation between 2C19 and S-mephenytoin 4′-hydroxylation
4. Evidence that CYP2C19 is the major (S)-mephenytoin 4′-hydroxylase in humans
5. Low frequency of defective alleles of cytochrome P450 enzyme 2C19 and 2D6 in the Turkish population
6. The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans
7. Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese
8. A new genetic defect in human CYP2C19: Mutation of the initiation codon is responsible for poor metabolism of S-mephenytoin
9. Interethnic differences in genetic polymorphism of debrisoquine and mephenytoin hydroxylation between Japanese and Caucasian populations
10. Metoprolol and mephenytoin oxidation polymorphism in Far Eastern Oriental Subjects: Japanese versus mainland Chinese
11. The mephenytoin (cytochrome P4502C19) and dextromethorphan (cytochrome P4502D6) polymorphisms in Saudi Arabians and Filipinos
12. Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele
13. Individual and ethnic differents in CYP2C19 activity in Chinese populations
14. Genetic analysis of the S-mephenytoin polymorphism in a Chinese population
15. Why are diazepam metabolism and polymorphic S-mephenytoin hydroxylatin associated with each other in Caucasian and Korean populations but not in Chinese populations
16. Effect of the gene dosage of CYP2C19 on diazepam metabolism in Chinese subjects
17. The pharmacokinetics of omeprazole in humans - A study of single intravenous and oral doses
18. +)ATPase
19. Effect of omeprazole - A gastric proton pump inhibitor - On pentagastrin stimulated gastric secretion in man
20. 5-Hydroxylation of omeprazole by human liver microsomal fractions from Chinese populations related to CYP2C19 gene dose and individual ethnicity
21. Phenotypic differences in mephenytoin pharmacokinetics in normal subjects
22. Induction of polymorphic 4′-hydroxylation of S-mephenytoin by rifampicin
23. Genetic analysis of the S-mephenytoin polymorphism in a Chinese population
24. The induction effect of rifampicin on activity of mephenytoin 4′-hydroxylase related to CYP2C19 * 2 mutation of CYP2C19 and gene dose